Skip to main content
Clinical Trials/NCT01533467
NCT01533467
Completed
Phase 2

Study of Perineal Protection Device

Helsingborgs Hospital1 site in 1 country1,200 target enrollmentNovember 2010
ConditionsPerineal Tear

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Perineal Tear
Sponsor
Helsingborgs Hospital
Enrollment
1200
Locations
1
Primary Endpoint
Grade I and II rupture during delivery
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

Objective:

To investigate the protective effects of a newly invented device for reducing tears in the perineum during vaginal childbirth.

Design:

A multicenter randomized control trial performed at three hospitals in Sweden, in Helsingborg, Lund and Malmö. Participants recruited are women with vaginal delivery (N=1200), cephalic presentation. They will be randomized to an intervention group, with a perineal protection device, and a control group deliver as normal.

Main outcome measures:

The effect on the frequency and extension of perineal ruptures grade I, II and anal sphincter rupture are measured.

Detailed Description

Perineal rupture shall be measured with a ruler. Anal sphincter ruptures be examined by physicians. Drawing be made of the tears by the midwife.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
November 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Helsingborgs Hospital
Responsible Party
Principal Investigator
Principal Investigator

Knut Haadem

Principal investigator

Helsingborgs Hospital

Eligibility Criteria

Inclusion Criteria

  • Vaginal delivery

Exclusion Criteria

  • Age below 18 years and no understanding of written and oral information.

Outcomes

Primary Outcomes

Grade I and II rupture during delivery

Time Frame: time at the delivery department (up to 12 months)

Number and extension of perineal tears during delivery

Study Sites (1)

Loading locations...

Similar Trials